By Dhirendra Tripathi
Investing.com – Johnson & Johnson (NYSE: JNJ ) shares fell more than 1% Friday after the Food and Drug Administration asked it to throw out 60 million doses of its Covid-19 vaccine that were made at a troubled Baltimore plant.
The FDA plans to allow about 10 million doses to be distributed in the U.S. or be sent to other countries, but with a warning that regulators cannot guarantee that Emergent Biosolutions (NYSE: EBS ), the company that operates the plant, followed good manufacturing practices, NYT said.
The FDA had been trying to figure out the fate of at least 170 million doses of vaccine left in limbo after the discovery of a major production mishap involving two vaccines manufactured at the site.
More than 100 million doses of the J&J vaccine and at least 70 million doses of AstraZeneca's (NASDAQ: AZN ) were put on hold after Emergent discovered in March that its workers had contaminated a batch of J&J with a key ingredient used to produce the U.K. company’s shots.
The Emergent plant remains shut.
J&J’s Covid vaccine is the only one in the world being given as a single shot. All others need two doses.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.